FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201105228> ?p ?o ?g. }

• W3201105228 abstract "Introduction: Proprotein convertase subtilisin/kexin type-9 (PCSK9) is an enzyme promoting the degradation of low-density lipoprotein receptors (LDL-R) in hepatocytes. Inhibition of PCSK9 has emerged as a novel target for lipid-lowering therapy. Monocytes are crucially involved in the pathogenesis of atherosclerosis. Circulating monocytes can be divided into three subsets. The aim of this study was to examine whether circulating levels of PCSK9 are associated with monocyte subsets. Methods: We included 69 patients with stable coronary artery disease. PCSK9 levels were measured and monocyte subsets were assessed by flow cytometry and divided into classical monocytes (CD14++CD16-; CM), intermediate monocytes (CD14++CD16+; IM) and non-classical monocytes (CD14+CD16++; NCM). Results: Mean age was 64 years and 80% of patients were male. Patients on statin treatment (n=55) showed higher PCSK9-levels (245.4 (206.0-305.5) ng/mL) as opposed to those without statin treatment (186.1 (162.3-275.4) ng/mL; p=0.05). In patients on statin treatment, CM correlated with circulating PCSK9 levels (R=0.29; p=0.04), while NCM showed an inverse correlation with PCSK9 levels (R=-0.33; p=0.02). Patients with PCSK9 levels above the median showed a significantly higher proportion of CM as compared to patients with PCSK-9 below the median (83.5 IQR 79.2-86.7 vs. 80.4, IQR 76.5-85.2%; p=0.05). Conversely, patients with PCSK9 levels >median were associated with a significantly lower proportion of NCM as compared to those with PCSK9 <median (10.2, IQR 7.3-14.6 vs. 14.3, IQR 10.9-18.7%; p=0.02). In contrast, IM showed no association with PCSK-9 levels. Conclusions: We hereby provide a novel link between PCSK9 regulation, innate immunity and atherosclerotic disease in statin-treated patients." @default.
• W3201105228 created "2021-09-27" @default.
• W3201105228 creator A5001892884 @default.
• W3201105228 creator A5003272933 @default.
• W3201105228 creator A5008682192 @default.
• W3201105228 creator A5023711238 @default.
• W3201105228 creator A5028316864 @default.
• W3201105228 creator A5032195145 @default.
• W3201105228 creator A5043847043 @default.
• W3201105228 creator A5045409568 @default.
• W3201105228 creator A5062353825 @default.
• W3201105228 creator A5077862111 @default.
• W3201105228 creator A5089382492 @default.
• W3201105228 date "2020-11-17" @default.
• W3201105228 modified "2023-09-24" @default.
• W3201105228 title "Abstract 15930: Circulating Levels of Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) are Associated With Monocyte Subsets in Patients With Stable Coronary Artery Disease" @default.
• W3201105228 doi "https://doi.org/10.1161/circ.142.suppl_3.15930" @default.
• W3201105228 hasPublicationYear "2020" @default.
• W3201105228 type Work @default.
• W3201105228 sameAs 3201105228 @default.
• W3201105228 citedByCount "0" @default.
• W3201105228 crossrefType "journal-article" @default.
• W3201105228 hasAuthorship W3201105228A5001892884 @default.
• W3201105228 hasAuthorship W3201105228A5003272933 @default.
• W3201105228 hasAuthorship W3201105228A5008682192 @default.
• W3201105228 hasAuthorship W3201105228A5023711238 @default.
• W3201105228 hasAuthorship W3201105228A5028316864 @default.
• W3201105228 hasAuthorship W3201105228A5032195145 @default.
• W3201105228 hasAuthorship W3201105228A5043847043 @default.
• W3201105228 hasAuthorship W3201105228A5045409568 @default.
• W3201105228 hasAuthorship W3201105228A5062353825 @default.
• W3201105228 hasAuthorship W3201105228A5077862111 @default.
• W3201105228 hasAuthorship W3201105228A5089382492 @default.
• W3201105228 hasConcept C114684123 @default.
• W3201105228 hasConcept C126322002 @default.
• W3201105228 hasConcept C134018914 @default.
• W3201105228 hasConcept C167672396 @default.
• W3201105228 hasConcept C170493617 @default.
• W3201105228 hasConcept C181199279 @default.
• W3201105228 hasConcept C203014093 @default.
• W3201105228 hasConcept C2776839432 @default.
• W3201105228 hasConcept C2778114629 @default.
• W3201105228 hasConcept C2778163477 @default.
• W3201105228 hasConcept C2778213512 @default.
• W3201105228 hasConcept C2778513237 @default.
• W3201105228 hasConcept C2778824825 @default.
• W3201105228 hasConcept C2778849439 @default.
• W3201105228 hasConcept C2779811187 @default.
• W3201105228 hasConcept C2780072125 @default.
• W3201105228 hasConcept C2780745583 @default.
• W3201105228 hasConcept C2780948078 @default.
• W3201105228 hasConcept C2781184567 @default.
• W3201105228 hasConcept C2781462264 @default.
• W3201105228 hasConcept C43554185 @default.
• W3201105228 hasConcept C55493867 @default.
• W3201105228 hasConcept C71924100 @default.
• W3201105228 hasConcept C86803240 @default.
• W3201105228 hasConcept C8891405 @default.
• W3201105228 hasConcept C90924648 @default.
• W3201105228 hasConceptScore W3201105228C114684123 @default.
• W3201105228 hasConceptScore W3201105228C126322002 @default.
• W3201105228 hasConceptScore W3201105228C134018914 @default.
• W3201105228 hasConceptScore W3201105228C167672396 @default.
• W3201105228 hasConceptScore W3201105228C170493617 @default.
• W3201105228 hasConceptScore W3201105228C181199279 @default.
• W3201105228 hasConceptScore W3201105228C203014093 @default.
• W3201105228 hasConceptScore W3201105228C2776839432 @default.
• W3201105228 hasConceptScore W3201105228C2778114629 @default.
• W3201105228 hasConceptScore W3201105228C2778163477 @default.
• W3201105228 hasConceptScore W3201105228C2778213512 @default.
• W3201105228 hasConceptScore W3201105228C2778513237 @default.
• W3201105228 hasConceptScore W3201105228C2778824825 @default.
• W3201105228 hasConceptScore W3201105228C2778849439 @default.
• W3201105228 hasConceptScore W3201105228C2779811187 @default.
• W3201105228 hasConceptScore W3201105228C2780072125 @default.
• W3201105228 hasConceptScore W3201105228C2780745583 @default.
• W3201105228 hasConceptScore W3201105228C2780948078 @default.
• W3201105228 hasConceptScore W3201105228C2781184567 @default.
• W3201105228 hasConceptScore W3201105228C2781462264 @default.
• W3201105228 hasConceptScore W3201105228C43554185 @default.
• W3201105228 hasConceptScore W3201105228C55493867 @default.
• W3201105228 hasConceptScore W3201105228C71924100 @default.
• W3201105228 hasConceptScore W3201105228C86803240 @default.
• W3201105228 hasConceptScore W3201105228C8891405 @default.
• W3201105228 hasConceptScore W3201105228C90924648 @default.
• W3201105228 hasIssue "Suppl_3" @default.
• W3201105228 hasLocation W32011052281 @default.
• W3201105228 hasOpenAccess W3201105228 @default.
• W3201105228 hasPrimaryLocation W32011052281 @default.
• W3201105228 hasRelatedWork W2278390890 @default.
• W3201105228 hasRelatedWork W2299182256 @default.
• W3201105228 hasRelatedWork W2509392579 @default.
• W3201105228 hasRelatedWork W2555963695 @default.
• W3201105228 hasRelatedWork W2617402612 @default.
• W3201105228 hasRelatedWork W3012122711 @default.
• W3201105228 hasRelatedWork W3046779074 @default.
• W3201105228 hasRelatedWork W3087443098 @default.
• W3201105228 hasRelatedWork W3162623042 @default.
• W3201105228 hasRelatedWork W3201105228 @default.
• W3201105228 hasVolume "142" @default.

• next